Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.
about
A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease.Gut Microbiota and Salivary Diagnostics: The Mouth Is Salivating to Tell Us Something.The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis.Metabolic programming of the epigenome: host and gut microbial metabolite interactions with host chromatin.Reciprocal interactions between bile acids and gut microbiota in human liver diseases.Gut Microbiota Dysbiosis Drives and Implies Novel Therapeutic Strategies for Diabetes Mellitus and Related Metabolic Diseases.A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses.Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders: A Clinical Perspective.Sequencing the gut metagenome as a noninvasive diagnosis for advanced nonalcoholic steatohepatitis.The Biological Clock: A Pivotal Hub in Non-alcoholic Fatty Liver Disease Pathogenesis.NAFLD: A gut microbiome signature for advanced fibrosis diagnosis in NAFLD.The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease.Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts.Bile Acids Activated Receptors Regulate Innate ImmunityMolecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese womenTherapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related MechanismsMetagenomic Approaches for Understanding New Concepts in Microbial ScienceComplex Network of NKT Cell Subsets Controls Immune Homeostasis in Liver and GutUpstream stimulating factor 1 suppresses autophagy and hepatic lipid droplet catabolism by activating mTOR
P2860
Q38675911-48BE8588-7A58-40D3-87F7-F9266852A206Q44009737-CCF008E9-00C0-4F14-AB32-98201A578C6DQ45071332-3F63BEDA-9B2D-4372-986C-9D5057B5C716Q46305658-314EEB1D-1A44-4291-BA55-BCA1E31CA3C6Q47389652-F63C0938-0E89-46FC-8B0E-C185518BA6A8Q49769640-61DACECF-6ED9-47E6-BAFA-EA7E42C04FB0Q50317278-F1677418-134D-4F6A-A6E5-8225FA3EEAE8Q52312388-2DD9F650-4775-4CEC-9D3B-D2C3DB12768CQ53149924-66CB5E3C-217B-4C2B-8829-0538536628D1Q53409142-929C5FDF-9290-4445-80C3-7700900336E3Q54470599-5A7E5013-1664-465E-ACEA-D369AD8E0EAFQ55450597-F31EC56E-E70B-4798-B254-29B194979B5DQ55656994-7FC094AE-8533-4B19-9C49-57BA67A94408Q57111959-8A14FA60-3905-4539-B460-0D2E8CCF49BBQ57518109-A7863169-958E-4371-BF85-628D1A3F934DQ58122029-6ADEBD0F-11ED-436E-B193-ECA98181EF90Q58711688-31ED3522-CB1F-4AF8-A411-DF69EBAEC8B3Q58750358-32EF66DA-46AC-47EF-81B0-74369A3B1DBBQ58772366-3259B6FB-C6BF-46BA-BC5F-79EB340FAD75
P2860
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Gut Microbiome-Based Metagenom ...... alcoholic Fatty Liver Disease.
@en
type
label
Gut Microbiome-Based Metagenom ...... alcoholic Fatty Liver Disease.
@en
prefLabel
Gut Microbiome-Based Metagenom ...... alcoholic Fatty Liver Disease.
@en
P2093
P2860
P50
P1433
P1476
Gut Microbiome-Based Metagenom ...... alcoholic Fatty Liver Disease.
@en
P2093
Archana Bhatt
Bernd Schnabl
Chi-Hua Chen
Claude B Sirlin
Cyrielle Caussy
Karen E Nelson
Lauren Brinkac
Marcus B Jones
Nicholas Schork
Niels Klitgord
P2860
P304
1054-1062.e5
P356
10.1016/J.CMET.2017.04.001
P577
2017-05-01T00:00:00Z